查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888544

新生儿筛检市场规模、份额和趋势分析报告：按产品、技术、检测类型、地区和细分市场预测（2025-2033 年）

Newborn Screening Market Size, Share & Trends Analysis Report By Product, By Technology, By Test Type, By Region, and Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

新生儿筛检市场摘要

全球新生儿筛检市场预计在 2024 年达到 9.0063 亿美元，预计到 2033 年将达到 17.9738 亿美元，2025 年至 2033 年的复合年增长率为 8.1%。

预计在预测期内，新生儿数量增加、新生儿先天性疾病病例增多、消费者意识提高以及各国政府的有利倡议和支持将推动多个计画和立法倡议，这些因素将推动市场发展。

根据联合国经济和社会事务部（UN DESA）发布的《2024年世界人口展望》，全球出生率预计将保持高位，2024年预计将有1.324亿婴儿出生。此外，世界卫生组织（WHO）估计，先天性疾病（子宫内发育过程中出现的结构或功能异常）将影响全球整体约6%的新生儿。一项更详细的评估——一项针对先天性疾病的全球、区域和国家筛检调查方法将有助于市场扩张。例如，美国的Levity公司于2023年11月发布了EONIS Q系统，该系统是一个获得CE-IVD认证的平台。这将使核准CE 标誌的国家的实验室能够引入新生儿脊髓性肌肉萎缩症 (SMA) 和严重联合免疫力缺乏(SCID) 的分子检测。

此外，新生儿先天性疾病盛行率的显着上升预计将对新生儿筛检市场的成长产生积极影响。根据世界卫生组织（世卫组织）2023年2月发布的数据，全球每年约有24万名新生儿在出生后28天内死于先天性疾病。此外，据估计，1个月至5岁儿童中约有17万例死亡是由先天性疾病造成的。另外，根据印度小儿科会的资料，印度每1,000名新生儿中就有2.1例患有先天性甲状腺机能低下症，先天性代谢性疾病的盛行率在2%至7.8%之间。预计新生儿先天性疾病的高发生率将促使检测普及率的提高，进而在2030年前加速市场成长。

此外，政府计画和相关法规的推出预计将为新生儿筛检的发展创造有利环境。世界各地的计画正引领新生儿筛检迈入基因组时代。例如，预计到2023年，将有10万名婴儿参与一项采用次世代定序（NGS）技术的新生儿筛检试验计画。 Illumina公司参与了至少九项国内外的大规模基因组新生儿筛检研究，筛检像多达4万名婴儿。这些研究包括美国的GUARDIAN计画、英国的Generation Study计画、澳洲的BabyScreen+计画以及比利时的BabyDetect计画。

预计随着新技术和治疗方案的引入，新生儿检测的需求将受到影响，这些新技术和治疗方案将能够诊断约29种新生儿疾病，包括半乳糖血症（GS）、苯酮尿症（PKU）、听力障碍和先天性甲状腺机能低下症（CH）。 2023年3月，美国疾病管制与预防美国（CDC）实验室科学部门的一组研究人员宣布推出改良型检测方法，这些方法采用先进技术诊断遗传性疾病。

目录

第一章新生儿筛检市场：调查方法与范围

第二章新生儿筛检市场：执行摘要

  • 市场概览
  • 产品概述
  • 技术概述
  • 测试类型概述
  • 竞争格局概述

第三章新生儿筛检市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 新生儿数量不断增加
    • 新生儿先天性疾病病例不断增加
    • 消费者意识的提高与有利的政策
    • 支持各级政府的多项计画和立法倡议
  • 市场限制因素分析
    • 高成本且取得途径有限
    • 基础设施和熟练劳动力短缺
    • 筛检方法的差异
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章新生儿筛检市场：产品估算与趋势分析

  • 新生儿筛检市场：产品差异分析
  • 装置
    • 设备市场，2021-2033年
  • 试剂
    • 试剂市场，2021-2033年

第五章新生儿筛检市场：技术预测与趋势分析

  • 新生儿筛检市场：技术波动分析
  • 串联式质谱质谱法
    • 串联式质谱质谱市场，2021-2033年
  • 脉搏血氧计
    • 脉搏血氧计市场，2021-2033年
  • 基于酵素的检测
    • 2021-2033年酵素分析方法市场
  • DNA检测
    • DNA检测市场，2021-2033年
  • 电泳
    • 电泳市场，2021-2033年

第六章新生儿筛检市场：检测类型估算与趋势分析

  • 新生儿筛检市场：检测类型差异分析
  • 干血斑测试
    • 2021-2033年干血斑检测市场
  • CCHD
    • 先天性心臟病检测市场，2021-2033年
  • 听力筛检
    • 2021-2033年听力筛检市场

第七章新生儿筛检市场：按地区分類的业务分析

  • 区域市场概览
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合资
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Masimo
    • Waters Corporation
    • Natus Medical
    • Trivitron Healthcare
    • GE Lifesciences
    • PerkinElmer Inc
    • AB SCIEX
    • Demand A/S
    • Parseq LAB
    • Otodynamics
    • Zentech
    • Centogene
Product Code: 978-1-68038-490-1

Newborn Screening Market Summary

The global newborn screening market size was estimated at USD 900.63 million in 2024 and is projected to reach USD 1,797.38 million by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer awareness, and favorable initiatives & support from various governments, which are organizing several programs & legislations, are factors estimated to propel the market over the forecast period.

According to the United Nations Department of Economic and Social Affairs (UN DESA) World Population Prospects 2024, the global number of births remains high, with an estimated 132.4 million babies born worldwide in 2024. Moreover, according to the World Health Organization (WHO), congenital disorders - structural or functional anomalies that occur during intra-uterine life - affect an estimated 6% of all births worldwide. In a more detailed assessment, a global, regional, and national epidemiology study of congenital disabilities found that in 2021, about 31.64 million children (aged 0-14 years) were living with congenital disabilities, representing a 6.68% increase since 1990. In addition, technological advancements in screening methodologies are also expected to boost the market. For instance, in November 2023, Revvity, Inc. (US) launched its EONIS Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

Furthermore, extensively increasing prevalence of congenital diseases in newborns is expected to have a positive impact on the newborn screening market growth. According to data published by WHO in February 2023, an estimated 240,000 newborns within 28 days of birth die each year globally due to congenital diseases. Congenital disorders are further responsible for an estimated 170, 000 child deaths in the age group of 1 month to 5 years. In addition, according to information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2 to 7.8%. Such a substantial occurrence of congenital diseases amongst newborns is likely to increase the adoption of tests, which is expected to accelerate the market growth by 2030.

In addition, the introduction of government programs and legislation is also expected to offer a favorable environment for newborn screening market growth. Programs around the globe bring newborn screening into the Genome Era. For instance, in 2023, an anticipated 100,000 infants participated in an NGS newborn screening pilot program. Illumina has participated in at least nine large-scale national and international genomic NBS investigations, screening up to 40,000 babies. This includes GUARDIAN in the U.S., Generation Study in the United Kingdom, BabyScreen+ in Australia, and BabyDetect in Belgium.

The demand for newborn procedures is expected to be influenced by the introduction of new technologies and the availability of treatment options enabling the diagnosis of about 29 possible disorders, such as galactosemia (GS), phenylketonuria (PKU), hearing disorders, and congenital hypothyroidism (CH) in neonates. In March 2023, a group of scientists at the Division of Laboratory Sciences, CDC, announced the introduction of improved tests that offer advanced technology for the diagnosis of genetic diseases.

Global Newborn Screening Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the newborn screening market based on product, technology, test type, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Tandem mass spectrometry
  • Pulse oximetry
  • Enzyme based assay
  • DNA assay
  • Electrophoresis
  • Others
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dry blood spot test
  • CCHD
  • Hearing screen
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Newborn Screening Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Test Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Newborn Screening Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshot
  • 2.3. Technology Snapshot
  • 2.4. Test Type Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Newborn Screening Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising neonatal population
    • 3.4.2. Increasing cases of congenital diseases in newborns
    • 3.4.3. Growing consumer awareness, and favorable initiatives
    • 3.4.4. Support from various governments organizing several programs & legislations
  • 3.5. Market Restraint Analysis
    • 3.5.1. High costs and limited accessibility
    • 3.5.2. Infrastructure and skilled workforce deficiencies
    • 3.5.3. Variations in screening practices
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Newborn Screening Market: Product Estimates & Trend Analysis

  • 4.1. Newborn Screening Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments market, 2021 - 2033 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents market, 2021 - 2033 (USD Million)

Chapter 5. Newborn Screening Market: Technology Estimates & Trend Analysis

  • 5.1. Newborn Screening Market: Technology Movement Analysis
  • 5.2. Tandem mass spectrometry
    • 5.2.1. Tandem mass spectrometry market, 2021 - 2033 (USD Million)
  • 5.3. Pulse oximetry
    • 5.3.1. Pulse oximetry market, 2021 - 2033 (USD Million)
  • 5.4. Enzyme based assay
    • 5.4.1. Enzyme based assays market, 2021 - 2033 (USD Million)
  • 5.5. DNA assays
    • 5.5.1. DNA assays market, 2021 - 2033 (USD Million)
  • 5.6. Electrophoresis
    • 5.6.1. Electrophoresis market, 2021 - 2033 (USD Million)

Chapter 6. Newborn Screening Market: Test Type Estimates & Trend Analysis

  • 6.1. Newborn Screening Market: Test Type Movement Analysis
  • 6.2. Dry blood spot test
    • 6.2.1. Dry blood spot test market, 2021 - 2033 (USD Million)
  • 6.3. CCHD
    • 6.3.1. CCHD test market, 2021 - 2033 (USD Million)
  • 6.4. Hearing screen
    • 6.4.1. Hearing screen test market, 2021 - 2033 (USD Million)

Chapter 7. Newborn Screening Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Bio-Rad Laboratories
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Agilent Technologies
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Masimo
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Waters Corporation
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Natus Medical
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Trivitron Healthcare
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. GE Lifesciences
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. PerkinElmer Inc
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. AB SCIEX
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Demand A/S
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Parseq LAB
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Otodynamics
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Zentech
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Centogene
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Newborn Screening Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 7 North America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 North America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 14 Canada Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Canada Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 Canada Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 17 Europe Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 18 Europe Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Europe Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Europe Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 21 UK Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 UK Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 UK Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 24 Germany Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Germany Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 26 Germany Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 27 France Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 France Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 France Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 30 Italy Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 Italy Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 Italy Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 33 Spain Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 Spain Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Spain Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 36 Denmark Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Denmark Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 38 Denmark Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 39 Sweden Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 Sweden Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 Sweden Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 42 Norway Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Norway Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Norway Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 49 Japan Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Japan Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 51 Japan Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 52 China Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 China Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 54 China Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 55 India Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 India Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 India Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 58 Australia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Australia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Australia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 63 South Korea Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 64 Thailand Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Thailand Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Thailand Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 67 Latin America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 68 Latin America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 69 Latin America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Latin America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 71 Brazil Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Brazil Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 Brazil Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 74 Mexico Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Mexico Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 76 Mexico Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 77 Argentina Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Argentina Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 79 MEA Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 81 MEA Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 MEA Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 89 UAE Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 90 UAE Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 91 UAE Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Newborn Screening Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Newborn Screening Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Newborn Screening Market driver impact
  • Fig. 14 Newborn Screening Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Newborn Screening Market: Product outlook and key takeaways
  • Fig. 19 Newborn Screening Market: Product movement analysis & market share 2024 & 2030
  • Fig. 20 Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Reagents & Assay Kits Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Newborn Screening Market: Technology outlook and key takeaways
  • Fig. 24 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
  • Fig. 25 Tandem Mass Spectrometry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Pulse Oximetry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Enzyme Based Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 DNA Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Electrophoresis Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Newborn Screening Market: Technology outlook and key takeaways
  • Fig. 31 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
  • Fig. 32 Dry Blood Spot Test Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Critical Congenital Heart Disease (CCHD) Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Hearing Screen Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global Newborn Screening Market: Regional movement analysis
  • Fig. 37 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Asia-Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 51 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Strategy framework